Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nephroblastoma (Wilms Tumour) Clinical Trial And Study
NCT00047138Phase 3Unknown
- Sponsor
- University of Leicester
- Start
- Jan 2001
- Modality
- DNA Intercalators/Alkylators
- Countries
- 4
01
Overview
A Phase 3 trial of doxorubicin in Wilms' tumor, sponsored by University of Leicester. Status: unknown.
02
Drugs
doxorubicin
03
Conditions
Wilms' tumor
Beyond the preview
Go deeper on NCT00047138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00047138.